Published

Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: eLife
Date: 2026-03-27
Source: Crossref
DOI: 10.7554/elife.104006
PubMed: 41891829

Authors

Schmidt Malin Hoffrichter Anne Davoudi Mahnaz Horschitz Sandra Lau Thorsten Meinhardt Marcus W Spanagel Rainer Ladewig Julia Köhr Georg Koch Philipp

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety Neuroplasticity Receptor Pharmacology Biomarkers Treatment-Resistant Depression Transcriptomics Other

Citation graph

40 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

10.1016/s0026-895x(25)09230-2 10.1073/pnas.212517999 10.1001/jamapsychiatry.2022.2096 10.1038/npp.2017.84 10.1007/s00213-017-4771-x 10.1038/nbt.1529 10.3389/fncel.2014.00401 10.1007/s11011-020-00547-w 10.1038/s41598-017-12779-5 10.3389/fpsyg.2019.01234 10.1038/s41386-022-01301-9 10.1016/j.celrep.2021.109836

Open datasets linked to this paper

Open dataset index

Data from: Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronsDryad · Open licence · Creative Commons Zero v1.0 Universal

Indexed papers citing this DOI

Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats2026-06-01 Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons2026-03-27

Related papers

Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe AnxietyClinicalTrials.gov · 2026-07-23 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant DepressionClinicalTrials.gov · 2022-05-20 TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-08-12 TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-08-12 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-06-25